**6. References**


The work highlighted in this review clearly demonstrates a role for the tumor microenvironment in the growth, progression and metastatic invasion of cholangiocarcinoma. There is obviously a strong interplay between the cells found in the stroma and cholangiocarcinoma cells with signaling molecules passing back and forth between the cell types to co-ordinately support an environment that nurtures tumor growth and suppresses innate immunity while conferring resistance to cytotoxic insults (both endogenous and chemotherapeutic). The mechanism by which each of the support cells found in the stroma of cholangiocarcinoma tumors are recruited and activated is still largely unknown. Therapeutic strategies designed to target the microenvironment rather than specifically targeting the cholangiocarcinoma cells might prove fruitful in the quest to

Portions of these studies were supported by an American Cancer Society Research Scholar award (RSC118760), an NIH K01 award (DK078532) and an NIH R03 award (DK088012) to Dr DeMorrow. This material is the result of work supported with resources and the use of

Achen, M., McColl, B., & Stacker, S. (2005). Focus on lymphangiogenesis in tumor metastasis. *Cancer Cell* Vol. 7 Issue 2 (Feb 2005). pp 121-7. ISSN 1535-6108 Achen, M. & Stacker, S (2008). Molecular control of lymphatic metastasis. *Ann N Y Acad Sci*

Aishima, S., Nishihara, Y., Iguchi, T., Taguchi, K., Taketomi, A., Maehara, Y., & Tsuneyoshi,

Aishima, S., Taguchi, K., Terashi, T., Matsuura, S., Shimada, M., & Tsuneyoshi, M. (2003).

Alpini, G., Prall, R., & LaRusso, NF. (2001). The pathobiology of biliary epithelia. *The Liver;* 

Alvaro, D., Barbaro, B., Franchitto, A., Onori, P., Glaser, S., Alpini, G., Francis, H., Marucci,

Ausprunk, D. H. & Folkman J. (1977). Migration and proliferation of endothelial cells in

Baldwin, M. E., Stacker, S.A & Achen, M.G. (2002). Molecular control of lymphangiogenesis.

*Bioessays* Vol 24, issue 11 (Nov 2002) pp 1030-40. ISSN 0265-9247.

M. (2008). Lymphatic spread is related to VEGF-C expression and D2-40-positive myofibroblasts in intrahepatic cholangiocarcinoma. *Mod Pathol* Vol 21, Issue 3(Mar

Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. *Mod Pathol* Vol 16, issue 10 (Oct 2003). pp 1019-

L., Sterpetti, P., Ginanni-Corradini, S., Onetti Muda, A., Dostal, D., De Santis, A., Atilli, A., Benedetti, A., & Gaudio, E. (2006). Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma. *Am J Pathol*

preformed and newly formed blood vessels during tumor angiogenesis. *Microvasc* 

facilities at the Central Texas Veterans Health Care System, Temple, Texas

Vol. 1131 (May 2008), pp 225-34. ISSN 0077-8923

2008), pp 256-64. ISSN 0893-3952.

*Biology & Pathobiology*, 4E: pp 421-435.

Vol 169, Issue 3 (Sep 2006), pp 877-88. ISSN 0002-9440.

*Res* Vol 14, Issue 1 (Jul 1977) pp 53-65. ISSN 0026-2862.

27. ISSN 0893-3952

**4. Conclusions** 

combat this devastating cancer.

**5. Acknowledgements** 

**6. References** 


by a decrease in the vascular endothelial growth factor expression. *Liver Int* Vol 29 Issue 7 (August 2009), pp 1031-42. ISSN 1478-3231.


Francis, H., DeMorrow S., Venter, J., Onori, P., White, M., Gaudio, E., Francis, T., Greene, J.,

Francis, H., Onori P., Gaudio, E., Franchitto, A., DeMorrow, S., Venter, J., Kopriva, S.,

Gale, N. W., Thurston G., Hackett, S.f., Renard, R., Wang, Q., McClain, J., Martin, C., Witte,

Gaudio, E., Barbaro B., Alvaro, D., Glaser, S., Francis, H., Ueno, Y., Meininger, C.J.,

Gladson, C. L. (1999). The extracellular matrix of gliomas: modulation of cell function. *J Neuropathol Exp Neurol* Vol 58, Issue 10 (Oct 1999), pp 1029-40. ISSN 0022-3069. Glaser, S. S., Gaudio E., & Alpini, G. (2010). Vascular factors, angiogenesis and biliary tract

Gores, G. J. (2003). Cholangiocarcinoma: current concepts and insights. *Hepatology* Vol 37,

Harder, J., Waiz O.,Otto, F., Geissler, M., Olschewski, M., Winhold, B., Blum, H.E.,

Hasita, H., Komohara Y., Okabe, H., Masuda, T., Ohnishi, K., Lei, X.F., Beppu, T., Baba, H.,

Iguchi, T., Yamashita N., Aishima, S., Kuroda, Y., Terashi, T., Sugimachi, K., Taguchi, K.,

Isomoto, H., Mott, J.L., Kobayashi, S., Werneburg, N.W., Bronk, S.F., Haan, S., & Gores, G.J.

epigenetic silencing. *Gastroenterology* Vol 132, Issue 1 (Jan 2007), pp 384-96. Kawahara, N., Ono, M., Taguchi, K., Okamoto, M., Shimada, M., Takenaka, K., Hayashi, K.,

Issue 7 (August 2009), pp 1031-42. ISSN 1478-3231.

7 Issue 10 (Oct 2009), pp 1704-13. ISSN 1557-3125.

Issue 5 (May 2003), pp 961-9. ISSN 0270-9139.

*Dev Cell* Vol 3, Issue 3 (Sept 2002), pp 411-23. ISSN 1534-5807.

cholangiocarcinoma. *Gut* In press.

0016-5085.

7056.

1007-9327.

1913-9. ISSN 1349-7006.

by a decrease in the vascular endothelial growth factor expression. *Liver Int* Vol 29

Tran, S., Meininger, C., & Alpini, G. (2011). Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human

Carpino, G., Mancinelli, R., White, M., Meng, F., Vetuschi, A., Sferra, R., & Alpini, G. (2009). H3 histamine receptor-mediated activation of protein kinase Calpha inhibits the growth of cholangiocarcinoma in vitro and in vivo. *Mol Cancer Res* Vol

C., Witte, M.H., Jackson, D., Suri, C., Campochiaro, P.A., Wiegand, S.J., & Yancopoulos, G.D. (2002). Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1.

Franchitto, A., Onori, P., Marzioni, M., Taffetani, S., Fava, G., Stoica, G., Venter, J., Reichenbach, R., DeMorrow, S., Summers, R., & Alpini, G. (2006). Vascular endothelial growth factor stimulates rat cholangiocyte proliferation via an autocrine mechanism. *Gastroenterology* Vol 130, Issue 4 (Apr 2006) pp 1270-82. ISSN

disease. *Curr Opin Gastroenterol*. Vol 26, Issue 3 (Jan 2010) pp 246-50. ISSN 1531-

Schmitt0Graeff, A., & Opitz, O.G. (2009). EGFR and HER2 expression in advanced biliary tract cancer. *World J Gastroenterol* Vol 15 Issue 36 (Sep 2009), pp 4511-7. ISSN

& Takeya, M. (2010). Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma. *Cancer Sci* Vol 101, Issue 8 (Aug 2010) pp

Taketomi, A., Maehara, Y., & Tsuneyoshi, M. (2009). A comprehensive analysis of immunohistochemical studies in intrahepatic cholangiocarcinoma using the survival tree model. *Oncology* Vol 76 Issue 4 (Sep 2009) pp 293-300. ISSN 1423-0232.

(2007). Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3

Mosher, D.F., Sugimachi, K., Tsuneyoshi, M., & Kuwano, M. (1998). Enhanced expression of thrombospondin-1 and hypovascularity in human cholangiocarcinoma. *Hepatology* Vol 28 Issue 6 (Dec 1998), pp 1512-7. ISSN 0270- 9139.


Mobius, C., Demuth C., Aigner, T., Wiedmann, M., Wittekind, C., Mossner, J., Hauss, J., &

Nagy, J. A., Vasile E., Feng, D., Sundberg, C., Brown, L.F., Detmar, M.J., Lawitts, J.A.,

Ogasawara, S., Yano H., Higaki, K., Takayama, A., Akiba, J., Shiota, K., & Kojiro, M. (2001).

Ohira, S., Sasaki M., Harada, K., Sato, Y., Zen, Y., Isse, K., Kozaka, K., Ishikawa, A., Oda,

Okabe, H., Beppu T., Hayashi, H., Horino, K., Masuda, T., Komori, H., Ishikawa, S.,

Olumi, A. F., Grossfeld G. D., Hayward, S.W., Carroll, P.R., Tisty, T.D., & Cunha, G.R.

Onimaru, M. and Yonemitsu Y. (2011). Angiogenic and lymphangiogenic cascades in the tumor microenvironment. *Front Biosci (Schol Ed)* Vol 3, pp 216-25. ISSN 1945-0524. Orimo, A. and Weinberg R. A. (2006). Stromal fibroblasts in cancer: a novel tumor-

Patel, T. (2002). Worldwide trends in mortality from biliary tract malignancies. *BMC Cancer*

Prakobwong, S., Gupta S. C., Kim, J.H., Sung, B., Pinlaor, P., Hiraku, Y., Wongkham, S.,

multiple cell signaling pathways. *Carcinogenesis.* In press ISSN 1460-2180. Prakobwong, S., Khoontawad, J., Yongvanit, P., Pairojkul, C., Hiraku, Y., Sithithaworn, P.,

Rasanen, K. and Vaheri A. (2010). Activation of fibroblasts in cancer stroma. *Exp Cell Res* Vol

Vol 33, Issue 8 (Oct 2007), pp 1025-9. ISSN 0748-7983.

Vol 20, Issue 1 (May 2001), pp 97-113. ISSN 1386-6346.

16 Issue 9 (Sep 2009), pp 2555-64. ISSN 1534-4681.

Vol 2 (May 2002), pp 10. ISSN 1471-2407.

(Jul 2011), pp 88-100. ISSN 1097-0215.

316, Issue 17 (Oct 2010), pp 2713-22. ISSN 1090-2422.

0022-1007.

9440.

4005.

ISSN 0008-5472.

Witzigmann, H. (2007). Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma. *Eur J Surg Oncol*

Benjamin, L., Tan, X., Manseau, E.J., Dvorak, A.M., & Dvorak, H.F.(2002). Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. *J Exp Med* Vol 196, Issue 11 (Dec 2002), pp 1497-506. ISSN

Expression of angiogenic factors, basic fibroblast growth factor and vascular endothelial growth factor, in human biliary tract carcinoma cell lines. *Hepatol Res*

DK., Nimura, Y., & Nakanuma, Y. (2006). Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-alpha and stromal-derived factor-1 released in stroma. *Am J Pathol* Vol 168, Issue 4 (Apr 2006), pp 1155-68. ISSN 0002-

Watanabe, M., Takamori, H., Iyama, K., & Baba, H. (2009). Hepatic stellate cells may relate to progression of intrahepatic cholangiocarcinoma. *Ann Surg Oncol* Vol

(1999). Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. *Cancer Res* Vol 59, Issue 19 (Oct 1999), pp 5002-11.

promoting cell type. *Cell Cycle* Vol 5, Issue 15 (Aug 2006) pp 1597-601. ISSN 1551-

Sripa, B., Pinlaor, S., & Aggarwal, B.B. (2011). Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of

Pinlaor, P., Aggarwal, B.B., & Pinlaor, S. (2011). Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis. *Int J Cancer* Vol 129 Issue 1


Umeshita, K., Dono, K., Wakasa, K., & Monden, M. (2006). Angiogenesis in cholangiocellular carcinoma: expression of vascular endothelial growth factor, angiopoietin-1/2, thrombospondin-1 and clinicopathological significance. *Oncol Rep* Vol 15 Issue 3 (Mar 2006), pp 525-32. ISSN 1021-335X.

